Status:
UNKNOWN
New Tools for Predicting Capillary Leak Shock During Dengue Fever
Lead Sponsor:
Centre Hospitalier de Cayenne
Collaborating Sponsors:
European Regional Development Fund
Conditions:
Dengue Fever
Children
Eligibility:
All Genders
5+ years
Phase:
NA
Brief Summary
Evaluate the prognostic value of different methods (Osmometry / clinical-biological score) compared to the occurrence of capillary leak shock during dengue fever.
Detailed Description
On the South American continent, dengue fever progressively progresses to hyperendemia with co-circulation of different serotypes. Among the complications of dengue fever, a frequent complication is t...
Eligibility Criteria
Inclusion
- Age\> = 5 years
- Patient / parent consent
- Exclude other pathology with capillary circulation problem (septic shock, anaphylaxis) All suspected dengue fever requiring hospitalization will be included, final inclusion being after biological confirmation (AgNS1, RT-PCR, serology).
Exclusion
- Age \<5 years
- Refusal to participate
- Unsigned consent
- Coinfection by another agent
- Patient under guardianship or curatorship.
Key Trial Info
Start Date :
May 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 14 2023
Estimated Enrollment :
342 Patients enrolled
Trial Details
Trial ID
NCT04422782
Start Date
May 14 2020
End Date
May 14 2023
Last Update
December 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospital of Cayenne
Cayenne, French Guiana, France, 97306